<DOC>
	<DOCNO>NCT00717054</DOCNO>
	<brief_summary>The purpose study compare incidence nausea , vomiting , need rescue medication , prolong PACU time , unplanned hospital admission patient high risk post-operative nausea vomiting ( PONV ) treat oral aprepitant without transdermal scopolamine preoperatively .</brief_summary>
	<brief_title>Comparison Aprepitant Versus Aprepitant Transdermal Scopolamine Preventing Postoperative Nausea Vomiting</brief_title>
	<detailed_description>Aprepitant , selective antagonist neurokinin-1 ( NK-1 ) receptor , block emetic effect substance P. NK-1 receptor find vagal afferent gastrointestinal tract nucleus tractus solitary brain . Substance P action NK-1 receptor central nervous system ( CNS ) one final pathway emetic response . Scopolamine antagonize muscarinic type 1 ( M1 ) histamine type 1 ( H1 ) receptor CNS , hypothalamus , vomit center . The noradrenergic system also suppress result diminish response vestibular stimulation . Surgical procedure , opioids , movement postoperatively stimulate vestibular system make scopolamine effective prophylaxis PONV . In adult undergo general anesthesia inhalational anesthetic agent , predictive risk factor PONV include female sex , history PONV motion sickness , nonsmoking status , use postoperative opioids . The frequency PONV 10 % zero , 21 % one , 39 % two , 61 % three , 79 % 4 risk factor . The type surgery also play major role . High risk procedure include intrabdominal , laparoscopic , orthopedic , major gynecologic , thyroid , otolaryngological , neurosurgical , breast , plastic surgery . Improving PONV prophylaxis would profound impact patient care . Decreasing incidence nausea , vomiting , need rescue medication , prolong PACU time , unplanned admission beneficial . Recent evidence suggest multiple drug therapy superior single agent . The correct preoperative treatment medication instrumental outcome . This study compare incidence nausea , vomiting , need rescue medication , prolong PACU time , unplanned hospital admission patient high risk PONV treat oral aprepitant without transdermal scopolamine preoperatively .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>Between 18 65 year age American Society Anesthesiology ( ASA ) physical status 13 If oral contraceptive , must willing use back method 1 month Must 2 risk factor PONV History vomit due middle ear infection , nervous system disorder , condition Procedure le 1 hour Pregnant breast feed Antiemetic medication previous 24 hour Narrowangle glaucoma Allergic belladonna alkaloid Hypersensitive barbiturate Prostate hypertrophy Severe hepatic disease On chemotherapy take aprepitant Fever Sepsis Taking follow medication : Orap , Seldane , Hismanal , Propulsid , Phenytoin , Phenothiazines , Tricyclic antidepressant , Meperidine , Tolbutamide , Aluminum Magnesium contain Antacids , Anticholinergics , Coumadin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>postoperative nausea vomit</keyword>
</DOC>